Mon, Jan 26, 2015, 1:49 PM EST - U.S. Markets close in 2 hrs 11 mins

Recent

% | $
Quotes you view appear here for quick access.

SIGA Technologies, Inc. Message Board

  • amlnlover100 amlnlover100 Jul 8, 2013 7:40 AM Flag

    Not Monkying Around

    Data from CMX001-201 Trial in Hematopoietic Stem Cell Transplant patients presented in Late-Breaking Poster Session at 24th International Congress of The Transplantation Society

    "Herve Mommeja-Marin, MD, Vice President of Clinical Research at Chimerix, presented the BKV data from the Phase 2 Study CMX001-201, which had as its primary objective the evaluation of CMX001 versus placebo for the prevention of cytomegalovirus (CMV) infection in 230 HSCT recipients. Phase 2 results presented elsewhere have shown that CMX001, at various doses, was active and well-tolerated in the prevention of CMV infection or disease. "

 
SIGA
1.41-0.07(-4.73%)1:44 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.